A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors
Clinical trial NCT07534813 · WITHDRAWN
Trial details
- NCT number
- NCT07534813
- Sponsor
- Grit Biotechnology
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2028-05-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.